Objectives To determine the prevalence of cerebral atrophy in a multi-ethnic systemic lupus erythematosus (SLE) cohort and to ...

Gradually spacing belimumab doses appears feasible in patients with prolonged remission from systemic lupus erythematosus, ...

While the treatment landscape for systemic lupus erythematosus (SLE) continues to evolve with increasing biologic adoption and a growing pipeline of novel therapies, new research from Spherix Global ...

Systemic lupus erythematosus is associated with higher risks for all-cause and cardiovascular mortality for up to 5 years after acute myocardial infarction, a study finds.

Systemic Lupus Erythematosus (SLE), commonly known as lupus, is a complex long-term disease.

An international group of lupus researchers have developed a new measurement tool to assess brain fog and cognitive symptoms ...

A complex and mysterious disease, the causes of systemic lupus erythematosus (SLE) remain unknown. In a new study, researchers discovered a mechanism that may contribute to lupus development and a ...

About 5 million people worldwide live with the autoimmune condition lupus. This condition can cause a range of symptoms, including tiredness, fever, joint pain and a characteristic butterfly-shaped ...

AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the ...

Systemic lupus erythematosus (SLE) is a chronic, complex autoimmune disease that can affect multiple organ systems, with disease severity and clinical manifestations varying considerably among ...

Medically reviewed by David Ozeri, MD Key Takeaways Lupus can cause hives in about 10% of cases.Hives in lupus last for more ...